CADMIUM (Cd 2ϩ ) is a nonessential heavy metal that is known as an important industrial and environmental pollutant and a contaminant of tobacco smoke. The wide environmental distribution of Cd 2ϩ has led to an increased interest in its toxicity and biological effects (41) . A focal point for chronic Cd 2ϩ nephrotoxicity is the proximal tubule (PT), particularly its S1 segment (14) . It is associated with a general transport defect of the PT, which mimics the de Toni-Debré-Fanconi syndrome. Renal dysfunction in the form of proteinuria, aminoaciduria, glucosuria, and phosphaturia has been demonstrated in persons occupationally exposed to Cd 2ϩ (for review, see Ref. 40) . Human studies indicate that 7% of the general population develops renal dysfunction from Cd 2ϩ exposure (14) . When free Cd 2ϩ enters the cytosol of PT cells, reactive oxygen species (ROS) are generated, partly as a consequence of Cd 2ϩ -induced displacement of endogenous redox active metals (Fe 2ϩ , Cu 2ϩ ) (29) and subsequent damage to critical organelles (e.g., mitochondria) (36) . ROS resulting from oxidative stress promote structural changes or misfolding of cellular proteins including vital membrane transporters, such as the Na ϩ -K ϩ -ATPase (38) . To overcome the toxic accumulation of oxidatively modified proteins, cells increase the rates of proteolysis of abnormal transporters, either by endocytosis and subsequent degradation by lysosomal proteases, or proteolysis via the ubiquitin-proteasome complex (26) . If this plethora of ROS-mediated stress events is not sufficiently balanced by repair processes, affected cells may be induced to undergo cell death via apoptosis or necrosis. We have shown that low micromolar Cd 2ϩ concentrations induce apoptosis, but not necrosis, of PT cells by a process involving ROS (38, 39) .
Apical endocytosis of Cd 2ϩ complexed to metallothionein (MT) represents the major form in which Cd 2ϩ is delivered to the kidneys in vivo (28) . This is because enterally absorbed Cd 2ϩ is initially taken up into the liver. Once taken up by cells, Cd 2ϩ binds to small molecules (such as amino acids) or peptides, such as glutathione (GSH), which contain a sulfhydryl group and protect the intracellular milieu from oxidative damage, or to proteins including MTs. At least four different MTs are known. MT-1 and MT-2, which are found expressed in epithelial cells, are small proteins of ϳ6 kDa that are distinguished by their high metal content (9) . MTs contain numerous thiol groups due to their high cysteine content, which provide the basis for high-affinity binding of many transition metals. MTs are highly inducible and accumulate intracellularly in response to a variety of stimulants, such as Cd 2ϩ (22) .
Because free cytosolic Cd 2ϩ is sequestered by GSH or by intracellularly induced MT, toxicity may occur if an imbalance between these protective factors and the cellular Cd 2ϩ load occurs. Some Cd 2ϩ bound to MT is also released from damaged cells into the plasma, from where CdMT complexes are easily filtered through the glomerulus and translocated from the primary urinary filtrate into renal PT cells (reviewed in Ref. 22) . It has been suggested that once taken up by endo/lysosomes, Cd 2ϩ may be freed from MT and subsequently transported into the cytoplasmic compartment, where the free Cd 2ϩ ion may trigger apoptosis and/or induce intracellular de novo MT synthesis. However, in vivo as well as in vitro studies have yielded conflicting results as to the nephrotoxic potency of cadmiummetallothionein (CdMT) (16, 18, 20, 22, 24, 31) .
The cellular processes underlying in vivo cadmium nephrotoxicity as well as the uptake pathways for Cd 2ϩ and CdMT in PT cells are poorly understood. Thus the present study was designed to determine the role of the endo/lysosomal uptake pathway for cell viability and MT levels in cultured immortalized rat PT cells exposed to CdCl 2 or Cd 7 MT-1.
EXPERIMENTAL PROCEDURES

Materials
The following reagents were obtained from the listed sources and used at the concentrations indicated in the text. Stock solutions of LY-294002 (Calbiochem, Bad Soden, Germany) were made by solubilization in dimethyl sulfoxide (DMSO). Polyvinylidene difluoride (PVDF) membranes were from NEN-Dupont (Bad Homburg, Germany). Enhanced chemiluminescence reagents and 109 CdCl2 with a specific activity of 50-1,000 Ci/g Cd 2ϩ were purchased from Amersham Pharmacia Biotech Europe (Freiburg, Germany). Chelex 100, chloroquine diphosphate, and metallothionein 1 (MT-1 from rabbit liver) were purchased from Sigma (Deisenhofen, Germany). Rat tail collagen type I (Sigma) was dissolved in 100 mM acetic acid. Hoechst 33342 (dissolved in H 2O) was from Calbiochem. Ethidium bromide (Sigma) was dissolved in 150 mM HEPES, pH 7.4. All other substances were from commercial sources and of analytic grade.
Antibodies. The mouse monoclonal antibody (E9) against horse metallothionein (MT-1 and MT-2) was obtained from DAKO Diagnostika (Hamburg, Germany). The mouse antilysosome-associated membrane protein 1 (LAMP1) monoclonal antibody (MAb) (Bioquote Limited, York, UK) was used for the detection of late endosomal and lysosomal membrane fractions. The rabbit polyclonal antibody against Rab5a (S-19) was from Santa Cruz Biotechnology (Santa Cruz, CA) and served as a marker of early endosomal vesicles. Donkey anti-mouse IgG coupled to indocarbocyanin (Cy3) was obtained from Dianova (Hamburg, Germany). Horseradish-peroxidase conjugated sheep anti-mouse or donkey anti-rabbit IgG were purchased from Amersham-Buchler (Braunschweig, Germany) and were used as secondary antibodies for immunofluorescence and immunoblotting, respectively.
Methods
Cell culture. Immortalized cells (WKPT-0293 Cl.2) of the S1 segment of the PT of normotensive Wistar-Kyoto rats were cultured as described earlier (38, 39) . Briefly, cells were maintained in renal tubular epithelium medium composed of Dulbecco's modified Eagle's medium (DMEM)/F-12 [nutrient mixture F-12 (Ham's); 1:1] and supplemented with 15 mM HEPES, 1.2 mg/ml NaHCO 3, 5 g/ml insulin, 5 g/ml transferrin, 10 ng/ml epidermal growth factor, 4 g/ml dexamethasone, 100 U/ml penicillin G, 100 g/ml streptomycin sulfate, and 5% fetal calf serum. Cells were plated on 25-cm 2 culture flasks, passaged at 80% confluence, and split 1:10 once a week. Drugs and solvents were applied 1 h before addition of CdCl 2, MT-1, or Cd7MT-1 for the times indicated. Media Ϯ drugs/solvents were replaced every 48 h.
109 Cd 2ϩ kinetic transport and inhibitor studies. Experiments were performed on cells seeded into six-well plates. The cell number per well (3-5 ϫ 10 5 cells) was adjusted to obtain cell confluence within 48 h after seeding.
109 Cd 2ϩ and 109 Cd 2ϩ -MT-1 uptake into PT cells was performed according to the method described by Templeton (37) with some modifications. All uptake measurements were performed in culture medium. The concentration of CdCl 2 was adjusted to 10 M from a 1,000-fold concentrated stock solution and labeled with 109 CdCl2 to give a final activity of 0.5 Ci/ml. MT-1 was saturated with 109 CdCl2 as described below. At particular time intervals, the labeling solution was removed from duplicate wells and the monolayers were washed three times with 1 ml of ice-cold Hanks' balanced salt solution (HBSS) containing 2 mM EGTA and solubilized in 1 M NaOH overnight. The 109 CdCl2 content in the solubilized cell layer was determined using a Cobra II Auto-Gamma counter (Packard Instrument, Meriden, CT) with the upper and lower energy limits of detection adjusted to 30 and 15 keV, respectively, yielding a counting efficiency of ϳ68%.
The lysosomotropic weak base chloroquine, which buffers acidic intracellular organelles (11) , was applied to cultured cells for 40 h together with 109 CdCl2 or 109 Cd7MT-1 and affected neither medium pH nor basal rates of apoptosis or necrosis at the tested concentration of 0.1 mM. The same applied to LY-294002 (5 M), a selective inhibitor of phosphatidylinositol 3-kinases (PI 3-kinase), which interferes with trafficking between endosomes and lysosomes (4, 10, 34) (higher concentrations of LY-294002 induced apoptosis of cultured cells). In control experiments, cells were exposed to 0.1% DMSO exactly as described for experimental drugs. These protocols were optimized such that application of the drugs did not induce apoptosis.
Fractionation of homogenate from PT cells by continuous sucrose gradient centrifugation. Cell monolayers of WKPT-0293 Cl.2 cells from four to six culture flasks were washed three times with HBSS, scraped off the culture dishes with a rubber policeman, pelleted by centrifugation at 14, 000 g for 5 min, and resuspended in homogenization buffer. Homogenization was performed in a cell disruption chamber (Parr Instrument, Moline, IL) by nitrogen pressure cavitation (1,000 lb./in. 2 for 10 min at 4°C) in 0.5 ml of ice-cold homogenizing buffer containing (in mM) 280 mannitol, 10 HEPES, 10 KCl, 1 MgCl2, adjusted to pH 7.0, and a protease inhibitor cocktail (10 M leupeptin, 2 mM benzamidine, and 0.1 mM Pefabloc SC). The homogenate was centrifuged at 50 g for 5 min, and the supernatant was collected. The pellet containing unbroken cells was resuspended in 0.5 ml of the same buffer and homogenized once more. After centrifugation at 50 g for 5 min, both supernatants were combined.
A continuous 0.25-2.0 M sucrose gradient was prepared in a total volume of 10 ml by mixing 0.25 M sucrose, 10 mM HEPES, and 1 mM EDTA (pH 7.0 with Tris) with 2.0 M sucrose, 10 mM HEPES, and 1 mM EDTA (pH 7.0 with Tris) in a linear gradient maker. The cell homogenate was loaded on top of the gradient and centrifuged at 25,000 g for 90 min, using a swing-out Beckman SW 41 rotor in a Beckman Optima L-70K ultracentrifuge (Beckman Coulter, High Wycombe, UK). The gradient was unloaded from the top, and ten 1-ml fractions were thus collected. Membrane pellets were obtained by centrifugation at 150,000 g for 90 min in a Beckman Optima MAX tabletop ultracentrifuge, using a TLA-55 fixed-angle rotor, and protein concentration was determined according to Bradford (3) . Samples were processed for immunoblotting.
Immunoblotting. Electrophoresis and blotting procedures were performed essentially as described earlier (38, 39) . Membrane proteins were separated by SDS-PAGE on 9% acrylamide Laemmli minigels and transferred onto PVDF membranes. After blocking with Tris-buffered saline containing 0.1% Tween 20 and 3% nonfat dry milk for 8 h, the membranes were incubated at 4°C with anti-LAMP1 (1:500) or anti-Rab5a (1:400) overnight, followed by horseradish peroxidase-conjugated secondary antibodies (1:10,000) for 1 h. The blots were developed in enhanced chemiluminescence reagents (ECLϩ; Amersham-Buchler), and signals were visualized on X-ray films. For documentation and quantification of LAMP1 and Rab5a expression, X-ray films from different experiments were scanned with a Fuji Film LAS1000plus system hardware and stored using LAS-1000 Pro Image Reader software (Fuji Photo Film, Tokyo, Japan). The intensity (optical density) of the chemiluminescence signals was quantified by using AIDA Image Analyzer software (Raytest Isotopenmessgerä te, Straubenhardt, Germany).
Measurement of MT content by indirect immunofluorescence labeling and quantitative morphometry.
The WKPT-0293 Cl.2 cells grown on glass coverslips were fixed in 4% paraformaldehyde/PBS for 30 min at room temperature (RT) (38) . All subsequent steps were also carried out at RT. Cells were rinsed three times for 5 min in PBS and permeabilized by incubation for 5 min in PBS containing 0.1% Triton X-100. After three rinses in PBS, coverslips were inverted on 100-l drops of a mouse MAb against a highly conserved peptide sequence (PNCSC) from MT-1 and MT-2 (E9; 1:300) and incubated for 1 h in a moist chamber. After three more rinses in PBS for 5 min, coverslips were incubated on drops of donkey anti-mouse IgG coupled to indocarbocyanin (Cy3; 1:600) for 30 min in the dark. After three more rinses for 5 min in PBS, coverslips were mounted with 2:1 Vectashield/ Tris ⅐ HCl (pH 8.0) (Vector Laboratories, Peterborough, UK). The cells were examined with an Olympus BX50F microscope equipped with ϫ40/0.75 and ϫ20/0.5 Olympus UPlanFI objectives, a dichroic NB filter block, and a narrow-band green fluorescence exciter filter (wavelength 530-550 nm). Images were recorded with a three-charge-coupled device color video camera (Sony DXC-950P) and digitized to 8 bits/pixel using software (-Slicer) developed by Prof. B. Lindemann (Department of Physiology, University of the Saarland, Homburg/ Saar, Germany) (38) .
Digitized images (ϫ400 magnification) were processed for documentation and a semiquantitative morphometric analysis using Adobe Photoshop Dl-4.01 software (Herzogenaurach, Germany). First, a level adjustment was performed by increasing the gamma value (slope of the curve) from 1.0 to 3.0 to raise the midtones without altering the range of brightness values (full range). Thus, by increasing the brightness of the midtones, weakly fluorescing images (e.g., controls) can be detected and analyzed. Images were then converted from a three-channel color model (RGB) to the grayscale mode. To minimize a bias due to cell proliferation (particularly in experiments in which time courses were analyzed), which occurs independently from the specific treatments applied, a fixed number of cells was selected for each image analyzed. To avoid a further bias caused by variations of fluorescence intensities, cells were selected for analysis that were neither too dark nor too bright, i.e., with a "representative" or "average" level of brightness. Images were analyzed twice by blind assignment to three different investigators. A freehand selection of five different cells was carried out with a mask, and a pixel histogram of selected cells was performed. The fluorescence intensity of an individual cell, which reflects MT expression, was estimated from the mean grayscale value, and a mean value was calculated from the values of five individual cells. For data analysis, cells from control and experimental conditions from an individual experiment were matched to account for variations in the labeling protocol and cell culture conditions. Cd 2ϩ toxicity and inhibitor studies. Cells were exposed to given concentrations of CdCl 2 (10 M), Cd7MT-1 (1.4 M MT-1 containing 7 Cd 2ϩ ions per molecule of MT-1), or MT-1 (1.4 M) for time periods varying between 4 and 72 h. At all incubation periods tested, CdCl 2 (10 M) did not affect cell proliferation, which has previously been assessed by comparison of cell numbers and percentages of mitotic figures (39) . To prepare Cd 7-reconstituted MT-1, apo-MT-1 was prepared by acidification of commercially available rabbit MT-1 in 0.1 N HCl, followed by filtration on a Centricon-3 (Amicon, Stonehouse, UK) equilibrated with 0.01 N HCl (30) . Apo-MT-1 (1 mM) was reconstituted with 10-fold Cd 2ϩ ions per mole of apo-MT-1 protein (K d Ϸ 10 Ϫ20 -10 Ϫ25 M). The unbound metals were removed with a 2:1 excess of Chelex 100. Inhibitors were applied as described for 109 Cd 2ϩ transport studies. Chloroquine (0.1 mM) or LY-294002 (5 M) were applied to cultured cells for various time periods in controls or together with CdCl 2 or Cd7MT-1.
Detection of apoptosis and necrosis by fluorescence microscopy. Cells (3 ϫ 10 5 ) cells were seeded into 35-mm tissue culture dishes and grown for 24 h before experiments were started. For detection of apoptosis and necrosis, cells were stained intravitally with the DNA dyes Hoechst 33342 (H-33342; 2 g/ml) for 20 min and ethidium bromide (EB; 5 g/ml) for 10 min, as previously described (39) . Under ultraviolet (UV) epi-illumination (excitation wavelength 330-380 nm; emission wavelength Ͼ430 nm), necrotic cells fluoresce pink due to EB, whereas normal and apoptotic cells emit blue fluorescence due to H-33342. EB stains nuclei from cells that have lost the integrity of their plasma membrane, i.e., have undergone necrosis. In contrast, the lipophilic DNA dye H-33342 freely enters viable as well as apoptotic cells. Apoptotic cells can be distinguished from viable cells by their nuclear morphology with nuclear condensation and fragmentation as well as by the higher intensity of blue fluorescence of the nuclei. After washing out of the dyes, cells were examined under a UV/VIS fluorescence microscope (IMT-2 Olympus). Cells from five microscopic fields (ϫ200 magnification) were counted per dish.
Statistics. All experiments were repeated at least three times with different batches of cell preparations. For kinetic studies, each time point was assayed in duplicate. Representative data or means Ϯ SD or SE of at least three different preparations are shown. Uptake and efflux data were curve fitted using the Sigma Plot 8.0 spreadsheet program. Statistical analysis was carried out with the SPSS 11.0 program. Unpaired Student's t-test was applied when two groups were compared. For more than two groups, statistical differences were compared using a one-way ANOVA and Bonferroni post hoc test for multiple comparisons, assuming equality of variance with Levene's test. Results with levels of P Յ 0.05 were considered to be statistically significant. Cd 7 MT-1 and homogenized, and subcellular membrane vesicles fractions were separated by ultracentrifugation of the homogenate layered on top of a continuous sucrose gradient ranging from 0.25 M (fraction 1) to 2.0 M (fraction 10) (Fig. 3A) . Immunoblotting of the membrane fractions with an antibody against the marker of early endosomal vesicles, Rab5a (5), showed an enrichment of Rab5a-associated vesicles in fractions 3-5, with a sharp peak in fraction 4 (Fig. 3, A and B) . LAMP1, a marker of late endosomes and lysosomes (6), was more broadly distributed between fractions 3 and 8, with a peak in fractions 5 and 6 (Fig. 3, A and B) .
RESULTS
Kinetics
109 Cd 2ϩ accumulated in fractions 4-7, with a maximum in fractions 5-7, which correlates best with the distribution of LAMP1 and partly overlaps with the distribution of Rab5a (Fig. 3B) .
MT Immunoreactivity of Rat PT Cells Exposed to CdCl 2 or Cd 7 MT-1
Another means of monitoring uptake of Cd 7 MT-1 is to determine the content of MT-1 in PT cells by quantitative morphometry following immunofluorescence labeling with a MAb that recognizes MT-1 and MT-2 (E9). Thus the antibody detects not only exogenously applied end endocytosed MT-1 or Cd 7 MT-1 but also endogenously expressed MT-1 and MT-2, which may be induced by cytosolic heavy metals such as Cd 2ϩ . In PT cells exposed to either 1.4 M MT-1 or Cd 7 MT-1 (Fig.  4) , MT immunoreactivity increased rapidly at 4 h and then slowed down at 20 and 48 h, suggesting cumulative intracellular uptake of Cd 7 MT-1/MT-1 via endocytosis. In cells exposed to 10 M CdCl 2 , MT immunoreactivity was not significantly different from background at 4 h but was followed by a large and significant increase of MT expression after 20 h, which remained at this level after 48 h and could represent Cd 2ϩ -induced MT-1 and MT-2 (Fig. 4) .
Time Course of Apoptosis in Rat PT Cells exposed to CdCl 2 or Cd 7 MT-1
Compared with controls, CdCl 2 significantly increased apoptosis at 4 h (controls: 3.0 Ϯ 0.3%; CdCl 2 : 5.0 Ϯ 0.5%; P Ͻ 0.01, n ϭ 6-7) (Fig. 5) . The maximal increase of apoptosis was observed at 24 h and decreased again at 72 h, which confirms previous observations (39) . Application of Cd 7 MT-1 for up to 12 h did not significantly alter rates of apoptosis compared with controls. Exposure times of 36 h clearly increased apoptosis, and rates of apoptosis reached the maximal levels obtained with CdCl 2 at 48 and 72 h. With equimolar concentrations of MT-1, rates of apoptosis were, however, not significantly different from that for controls (Fig. 5) , indicating that the protein moiety of Cd 7 MT-1 does not contribute to the development of apoptosis. With CdCl 2 , MT-1 and Cd 7 MT-1 rates of necrosis were not significantly different from that for controls (data not shown), similar to previously published reports (39) .
Effect of Endo/Lysosomal Inhibitors on MT Immunoreactivity in Rat PT Cells Exposed to CdCl 2 or Cd 7 MT-1
Basal MT levels were similar in controls and in cells treated with the endo/lysosomal inhibitors chloroquine (0.1 mM) or LY-294002 (5 M) for 48 h, respectively, suggesting that the drugs do not affect basal MT expression in PT cells (data not shown). PT cells were also exposed to CdCl 2 or Cd 7 MT-1 for 48 h, a period that demonstrated significant increase of MT levels with both conditions tested (see Fig. 4B ), without or with coincubation with the drugs (Fig. 6 ). When cells were exposed to chloroquine or LY-294002, MT immunoreactivity induced by exposure to 10 M CdCl 2 for 48 h did not statistically differ from that measured in cells with no drug exposure. These values were, however, significantly different from the basal levels of MT found in cells with no Cd 2ϩ exposure. After application of 1.4 M Cd 7 MT-1 for 48 h, coincubation with chloroquine or LY-294002 significantly reduced MT immunoreactivity (both conditions: P Ͻ 0.01 compared with condition without drug). In line with these observations, coincubation of PT cells exposed to 109 Cd 7 MT-1 with 0.1 mM chloroquine or 5 M LY-294002 strongly reduced 109 Cd 2ϩ distribution in all membrane vesicle fractions investigated (see Fig. 3B ).
Effect of Endo/Lysosomal Inhibitors on Apoptosis in Rat PT Cells Exposed to CdCl 2 or Cd 7 MT-1
Inhibitors were tested in cells exposed to CdCl 2 or Cd 7 MT-1 for 48 h because of the similar rates of apoptosis (see Fig. 5 ). As shown in Fig. 7 , the increase of apoptosis induced by CdCl 2 or Cd 7 MT-1 was statistically significant. Chloroquine (0.1 mM) did not affect basal levels of apoptosis, but it virtually abolished 109 Cd 2ϩ content of membrane vesicle fractions was determined using a gamma counter. Data are means Ϯ SD of 6 different membrane vesicle preparations. apoptosis induced by Cd 7 MT-1, whereas apoptosis induced by CdCl 2 was not affected. With LY-294002 (5 M), similar results were observed (Fig. 7) .
DISCUSSION
Cd 2ϩ Transport Into PT Cells
Apical uptake of free Cd 2ϩ . At the apical side, in vivo perfusion and studies with isolated PT segments or cell lines indicate that Cd 2ϩ is avidly taken up at the luminal membrane in all three segments (S1, S2, and S3), but most rapidly in S1 segments (for review, see Refs. 14, 40, 41). In WKPT-0293 Cl.2 cells, Cd 2ϩ uptake consisted of two components, similar to previous descriptions in LLC-PK1 cells (37) . A temperature-insensitive component was likely caused by surface binding of 109 Cd 2ϩ to cell membranes, and the temperaturesensitive part represented intracellular transport. Significant 109 Cd 2ϩ uptake was observed at a time point as early as 3.5 h of exposure, increased linearly over a period of up to 24 h, and saturated at 40 h (Fig. 1) . Uptake of free 109 Cd 2ϩ was not affected by chloroquine or LY-294002 (Fig. 2) , which indicates that endo/lysosomal acidification and/or trafficking is not involved in the uptake process. It has been suggested that Cd 2ϩ may cross the apical membrane through Ca 2ϩ channels, but this evidence is derived from data in hepatocytes obtained with the use of inhibitors of L-type Ca 2ϩ channels. In renal cells, the lack of effect of Ca 2ϩ channel blockers argues against a significant contribu- Fig. 1) , suggesting that the uptake of Cd 7 MT-1 by PT cells might involve several time-consuming steps. Current models assume that Cd 7 MT is taken up at the apical membrane of PT cells, particularly in the S1 and S2 segments (12) , the site of Cd 2ϩ nephrotoxicity, by what is thought to be receptor-mediated endocytosis (RME) (reviewed in Ref. 22 ) and then sorted to the lysosomal compartment. In a manner similar to PT reabsorption of other low-molecularweight proteins (for review, see Ref. 8), uptake of Cd 7 MT is probably triggered by binding to the promiscuous multiligand receptor proteins megalin and cubilin, followed by endocytosis of the megalin-Cd 7 MT complex. Subsequent steps may involve pH-dependent release of megalin from its ligand in endosomes, recycling of megalin to the plasma membrane, and fusion of the Cd 7 MT-containing late endosomes with lysosomes. In the lysosomes, the MT moiety may be degraded by acidic proteases, which frees Cd 2ϩ for transport into the cytoplasmic compartment. This model, for which evidence is still lacking, is nevertheless supported by data demonstrating that acute uptake of Cd 7 MT by the kidney in rats is blocked by low-molecular-weight proteins, including ␤ 2 -microglobulin (2), a ligand that binds megalin (8) . Application of the weak bases NH 4 Cl and chloroquine to dissipate the intraorganellar acidic pH, or use of the PI 3-kinase inhibitor LY-294002, which prevents endosomal receptor recycling and interferes with vesicular transport to lysosomes, strongly inhibited 109 Cd 7 MT-1 uptake (Fig. 2) , providing supporting evidence that apical uptake of Cd 7 MT takes place through RME. The colocalization of markers of the endo/lysosomal pathway (LAMP1, Rab5a) with 109 Cd 7 MT-1 accumulation into membrane vesicles and the inhibition of 109 Cd 7 MT-1 uptake by chloroquine and LY-294002 demonstrates that Cd 7 MT is transported into endosomes and lysosomes (Fig. 3) .
Previous in vivo as well as in vitro studies on isolated rat kidney cortex endosomes have suggested that nephrotoxicity of Cd 2ϩ and Cd 7 MT is partly mediated by impaired endo/lysosomal trafficking and vesicle recycling (19, 33) in PT cells and is caused by inhibition of endo/lysosomal V-ATPase by cytosolic Cd 2ϩ (19) . This is in contrast to the results of the present study, which demonstrates that endocytosis is unaffected in cells exposed to 1.4 M Cd 7 MT-1 (Figs. 1-3 ) and is actually a prerequisite for apoptosis of PT cells to develop (Fig. 7) . First, it could be argued that possible differences may exist between the models used (in vivo animal experiments vs. cultured cells). In addition, because of the high affinity of free Cd 2ϩ to cytosolic proteins, such as GSH or MT, it has to be assumed that free cytosolic Cd 2ϩ concentrations in cultured cells exposed to 1.4 M Cd 7 MT-1 do not exceed submicromolar concentrations, whereas in the study by Sabolic and coworkers (19) , Cd 2ϩ inhibited endosomal acidification with a K i of ϳ25-50 M. Nevertheless, the low free cytosolic Cd 2ϩ concentrations obtained in our cultured PT cells are sufficient to induce significant levels of apoptosis within 40 h (Fig. 5) . Our experimental in vitro model actually adequately mimics long-term animal models of chronic Cd 2ϩ toxicity, where proximal tubule damage requires weeks to months to develop. Thus it is worth emphasizing that the toxic effects of Cd 2ϩ (and Fanconi syndrome-associated features) appear to depend on RME of Cd 7 MT and not on an inhibitory effect of cytosolic Cd 2ϩ on endo/lysosomal function.
A crucial step in the cascade of events leading to cellular toxicity induced by Cd 7 MT should be the release of free Cd 2ϩ from the lysosomes into the cytosol. How does this transmembrane movement of Cd 2ϩ into the cytosol occur? It is thought that Cd 2ϩ is transported out of the endo/lysosome into the cytosol by a carrier-mediated process. The current dogma is that because Cd 2ϩ is a nonessential metal, it must be transported by proteins with native ligands of similar chemical characteristics. , and also Cd 2ϩ ), is proton coupled, and has been localized in endo/lysosomes of epithelial cells (17) . Although DMT1 is expressed in PT cells, its cellular localization has not yet been determined with certainty, and its role in Cd 2ϩ toxicity of PT cells remains to be investigated.
Origin of MT in PT Cells Exposed to Cd 2ϩ or Cd 7 MT-1
Less than 10% of the Cd 2ϩ taken up at the luminal membrane of PT is subsequently transported across the basolateral membrane, indicating that most of the transported Cd 2ϩ is sequestered within the epithelial cells (41) . Once taken up into PT cells, Cd 2ϩ binds to small molecules (such as amino acids) or peptides, such as GSH, which contain a sulfhydryl group and protect the intracellular milieu from oxidative damage, or to proteins, such as MT. MT is thought to have several functions, including essential element homeostasis and toxic metal detoxification (22) .
The kinetics of MT immunoreactivity in CdCl 2 -and Cd 7 MT-1-exposed cells and the inhibitor studies provide some clues as to the origin of intracellular MT. At early time points (4 h), MT immunoreactivity of cells exposed to Cd 7 MT-1 was increased (though not significantly) compared with background levels (Fig. 4B) , which argues against de novo synthesis of MT and favors an exogenous source of MT. Furthermore, inhibition of the endo/lysosomal pathway significantly decreased MT immunoreactivity in PTC exposed to Cd 7 MT-1 ( Fig. 6 ) and prevented accumulation of 109 Cd 7 MT-1 into endo/lysosomes (Fig. 3B ), suggesting that a main source of MT in these cells is endocytosed extracellular Cd 7 MT-1 (though induction of endogenous MT-1/MT-2 via free cytosolic Cd 2ϩ released from endo/lysosomes may also contribute to cellular MT levels). In contrast, in cells treated with CdCl 2 , MT immunoreactivity was not different from that in controls after 4 h, which is in agreement with previous studies in PT cell lines showing induction of MT synthesis not earlier than 3-6 h after exposure to micromolar concentrations of CdCl 2 at the apical cell side and maximal induction 24-48 h after treatment (13, 32) . At 24 h, the increase of cellular MT levels widely exceeded that observed in PT cells exposed to Cd 7 MT-1. Moreover, chloroquine and LY-294002 had no effect on MT expression of PT cells exposed to CdCl 2 (Fig. 6) . The data therefore indicate that the source of MT in CdCl 2 -treated PT cells is unrelated to endo/ lysosomal uptake. Because intracellular MT exists in at least three forms, cytosolic apo-MT, nuclear MT, and lysosomal MT, each displaying different turnover rates (35) , it is possible that MT induced by cytosolic Cd 2ϩ uptake rather represents induction of cytosolic and/or nuclear MT (see review, Ref. 9). Cytosolic uptake of Cd 2ϩ may increase MT expression as the result of chemical induction of the MT gene through metal responsive elements (1) . It is interesting to note that MT was also found expressed in the nucleus (Fig. 4A) . Its function there is not completely clear; MTs may protect DNA against oxidative damage. MT protein has been found localized in the nucleus during S phase. The mRNA encoding the MT-1 isoform has a perinuclear localization and is associated with the cytoskeleton; this targeting, due to signals within the 3Ј-untranslated region, facilitates nuclear localization of MT-1 during S phase. Furthermore, recent evidence suggests that the perinuclear localization of MT mRNA is im-portant for the function of MT in a protective role against DNA damage and apoptosis induced by external stress (9) .
Apoptotic Processes in PT Cells Exposed to Cd 2ϩ
or Cd 7 
MT-1
In cultured immortalized cells (WKPT-0293 Cl.2) from the S1 segment of the rat PT, we have previously demonstrated that application of CdCl 2 (10 M) induces apoptosis within 3-4 h, but not necrosis, by a mechanism involving production of ROS (39) . We also observed a biphasic time dependence of Cd 2ϩ -induced apoptosis in rat PT cells exposed to 10 M CdCl 2 : after rapid onset, Cd 2ϩ -dependent apoptosis decreased with prolonged Cd 2ϩ application, which partly involved upregulation of the multidrug transporter MDR-1 (39) . Figure 6 shows confirmation of these observations by application of 10 M CdCl 2 to WKPT-0293 Cl.2 cells for up to 72 h.
It has been proposed that the Cd 2ϩ -MT protein complex is highly toxic to the kidney after renal tubular reabsorption and induces apoptosis of PT cells (21, 23, 24, 27) . However, other in vivo studies and particularly in vitro studies with different kidney cell lines have been less conclusive: when HEK-293 cells were exposed to Cd 2ϩ -MT (10-59 g/ml protein), apoptosis was observed after 48 h of exposure (18) . In contrast, exposure of LLC-PK1 cells with up to 100 M Cd 2ϩ -MT for 24 h failed to induce apoptosis, whereas 10 M CdCl 2 did induce apoptosis (20) . The experiments of Fig. 5 reconcile this apparent discrepancy from the literature by demonstrating the critical importance of the time period of exposure with Cd 7 MT-1 in PT cell lines.
The delayed onset of apoptosis with Cd 7 MT-1 compared with the rapid induction of apoptosis with CdCl 2 , whereas no apoptosis was observed with MT-1, suggests that delivery of free Cd 2ϩ into the cytosol is critical for development of apoptosis. It also indicates that toxicity induced by Cd 7 MT-1 might involve several time-demanding processes, as expected for Cd 2ϩ -MT uptake up at the apical membrane of PT cells by receptor-mediated endocytosis and sorting to the lysosomal compartment. When the effect of chloroquine and LY-294002, which interfere with endo/lysosomal trafficking and protein degradation, was tested on the rates of apoptosis induced by CdCl 2 or Cd 7 MT-1, both drugs strongly reduced apoptosis induced by Cd 7 MT-1 but not by CdCl 2 (Fig. 7) . This finding suggests that induction of apoptosis by Cd 7 MT-1 in PT cells requires integrity of vesicular trafficking to lysosomes and adequate functional activity of lysosomal proteases. In contrast, both compounds did not affect cell death rates in cells exposed to CdCl 2 (Fig. 7) . Further studies on the cellular and molecular mechanisms involved in endocytosis and trafficking of the Cd 7 MT-1 complex in PT cells are required to provide a better understanding of Cd 2ϩ (and other heavy metal) nephropathies.
